Prosecutors rope Pfizer into fast-growing copay assistance probe

Pfizer plant hit with warning letter has history of FDA problems

Pfizer's new Inflectra biosim data puts J&J's Remicade on notice in Crohn's

AstraZeneca's latest Kondo-izing move: A $250M-plus deal for cancer med Zoladex

Teva catches break as warning letter looks to delay Momenta Copaxone generic